FR2305984B1 - - Google Patents

Info

Publication number
FR2305984B1
FR2305984B1 FR7609359A FR7609359A FR2305984B1 FR 2305984 B1 FR2305984 B1 FR 2305984B1 FR 7609359 A FR7609359 A FR 7609359A FR 7609359 A FR7609359 A FR 7609359A FR 2305984 B1 FR2305984 B1 FR 2305984B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7609359A
Other versions
FR2305984A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2305984A1 publication Critical patent/FR2305984A1/fr
Application granted granted Critical
Publication of FR2305984B1 publication Critical patent/FR2305984B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
FR7609359A 1975-04-02 1976-03-31 Nouveaux esters de quinoxaline-1,4-dioxyde et leur utilisation comme agents antibacteriens et promoteurs de croissance Granted FR2305984A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/564,363 US3966951A (en) 1975-04-02 1975-04-02 Esters of quinoxaline-1,4-dioxides

Publications (2)

Publication Number Publication Date
FR2305984A1 FR2305984A1 (fr) 1976-10-29
FR2305984B1 true FR2305984B1 (fr) 1979-10-05

Family

ID=24254164

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7609359A Granted FR2305984A1 (fr) 1975-04-02 1976-03-31 Nouveaux esters de quinoxaline-1,4-dioxyde et leur utilisation comme agents antibacteriens et promoteurs de croissance

Country Status (11)

Country Link
US (1) US3966951A (fr)
JP (1) JPS51122082A (fr)
BE (1) BE840279A (fr)
DE (1) DE2608516A1 (fr)
DK (1) DK143676A (fr)
FR (1) FR2305984A1 (fr)
GB (1) GB1482896A (fr)
IE (1) IE42399B1 (fr)
IT (1) IT1066071B (fr)
LU (1) LU74696A1 (fr)
NL (1) NL160556C (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348389A (en) * 1980-08-07 1982-09-07 International Minerals & Chemical Corp. Quinoxaline adducts useful as anthelmintics
US4658028A (en) * 1980-08-07 1987-04-14 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4656276A (en) * 1980-08-07 1987-04-07 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4720548A (en) * 1980-08-07 1988-01-19 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4661593A (en) * 1980-08-07 1987-04-28 Angus Chemcial Company Quinoxaline adducts useful as anthelmintics

Also Published As

Publication number Publication date
IT1066071B (it) 1985-03-04
GB1482896A (en) 1977-08-17
LU74696A1 (fr) 1977-02-02
IE42399B1 (en) 1980-07-30
DK143676A (da) 1976-10-03
BE840279A (fr) 1976-10-01
JPS5526139B2 (fr) 1980-07-11
DE2608516A1 (de) 1976-10-07
JPS51122082A (en) 1976-10-25
NL160556B (nl) 1979-06-15
NL160556C (nl) 1979-11-15
US3966951A (en) 1976-06-29
FR2305984A1 (fr) 1976-10-29
NL7603338A (nl) 1976-10-05

Similar Documents

Publication Publication Date Title
FR2335963B1 (fr)
JPS5526139B2 (fr)
FR2313132B2 (fr)
JPS5338772B2 (fr)
FR2301763B2 (fr)
JPS51117850U (fr)
JPS51161933U (fr)
JPS51155953U (fr)
JPS51145540U (fr)
JPS51107704U (fr)
CH600145A5 (fr)
CH598144A5 (fr)
CH606300A5 (fr)
CH603190A5 (fr)
CH603126A5 (fr)
CH602878A5 (fr)
CH602871A5 (fr)
CH602487A5 (fr)
CH602050A5 (fr)
CH601774A5 (fr)
CH601653A5 (fr)
CH601562A5 (fr)
CH601529A5 (fr)
CH600650A5 (fr)
DD121363A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse